AbbVie acquires Syndesi Therapeutics in $1bn deal pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Novo Holdings Portfolio Company Syndesi Therapeutics acquired by AbbVie· Deal value of US$ 1 billion with US$ 130 million upfront· Novo Holdings co-created Syndesi Therapeutics in partnership with UCB Pharma and co-led the Series A financing&m.
AbbVie buys Syndesi Therapeutics in what could be a $1B deal - Chicago Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.